NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity
Cellular and Molecular Biology · 2023
DOI: 10.14715/cmb/2023.69.9.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2023. Verfasst von Dilsah Ezgi Yilmaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. dilsahezgikucuk@hotmail.com. Hauptthemen laut MEDLINE: NF-kappa B, I-kappa B Kinase. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The nucleotide-binding oligomerization domain-like receptor X1 (NLRX1) has been associated with various anti-inflammatory mechanisms. We investigated whether the NLRX1 ligand docosahexaenoic acid (DHA) ameliorates lipopolysaccharide (LPS)-induced inflammatory hyperalgesia by interacting with tumor necrosis factor receptor-associated factor 6 (TRAF6)/inhibitor of kB (IkB) kinase (IKK)/IkB-a/nuclear factor-κB (NF-κB) signaling pathway in the central nervous system. Reaction time to thermal stimuli within 30 seconds was measured in male mice injected with saline, lipopolysaccharide (LPS), and/or DHA after 6 hours using the hot plate test. Co-immunoprecipitation and immunoblotting studies were performed to determine the activation of the TRAF6/IKK/IkB-a/NF-kB pathway in the brains and spinal cords of animals. Latency to the thermal stimulus was reduced by 30% in LPS-injected endotoxemic mice compared with saline-injected mice. Treatment with DHA significantly improved latency compared with endotoxemic mice. In the brain and spinal cord of LPS-injected mice, treatment with DHA also prevented the increase in the expression and/or activity of (1) IKKa/IKKβ, IKKg, and K63 U in the NLRX1-immunoprecipitated tissues, (2) IKKa/IKKβ, K63 U, and K48 U in the IKKg-immunoprecipitated tissues, and (3) IkB-α, NF-kB p65, and interleukin-1β associated with decreased IkB-α expression. These findings suggest that inhibition of IKK/IkB-a/NF-kB signaling by dissociation of NLRX1 from TRAF6 in response to LPS treatment contributes to the protective effect of DHA against inflammatory hyperalgesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. dilsahezgikucuk@hotmail.com.
- Department of Pharmacy Services, Health Services Vocational School, Tarsus University, Tarsus, Mersin, Turkey. pnr.snl@hotmail.com.
- Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. meryemtemiz88@gmail.com.
- Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. seyhansahan06@gmail.com.
- Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey. btunctan@gmail.com.
Zitieren
APA
Yilmaz, D. E., Senol, S. P., Temiz-Resitoglu, M., Sahan-Firat, S., & Tunctan, B. (2023). NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2023.69.9.3
Vancouver
Yilmaz DE, Senol SP, Temiz-Resitoglu M, Sahan-Firat S, Tunctan B. NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity. Cellular and Molecular Biology. 2023. doi:10.14715/cmb/2023.69.9.3
BibTeX
@article{Yilmaz2023,
author = {Yilmaz, Dilsah Ezgi and Senol, Sefika Pinar and Temiz-Resitoglu, Meryem and Sahan-Firat, Seyhan and Tunctan, Bahar},
title = {NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IκB-α/NF-κB signaling pathway activity},
journal = {Cellular and Molecular Biology},
year = {2023},
doi = {10.14715/cmb/2023.69.9.3}
}
EUVIMED